Table 1.

Prognostic role of EZH2 in diverse cancers through OncoLnc

Cancer	Cox	P-value	FDR	Rank	Median	Mean
BLCA	0.032	7.00e-01	8.58e-01	13,285	475.71	599.61
BRCA	0.082	3.50e-01	7.03e-01	8182	395.74	504.19
CESC	− 0.327	1.60e-02	2.05e-01	1239	1033.8	1118.51
COAD	− 0.147	1.50e-01	5.58e-01	4290	657.07	697.51
ESCA	0.001	9.90e-01	9.95e-01	16,624	482.73	573.25
GBM	− 0.037	6.90e-01	9.58e-01	12,003	598.43	689.2
HNSC	− 0.158	2.40e-02	2.46e-01	1590	479.81	577.87
KIRC	0.292	2.30e-04	1.62e-03	2346	126.98	149.04
KIRP	0.527	7.90e-04	8.76e-03	1477	123.29	140.76
LAML	− 0.028	8.20e-01	9.43e-01	13,200	1041.46	1043.88
LGG	0.277	6.20e-03	1.62e-02	6414	216.22	286.97
LIHC	0.478	2.80e-06	1.23e-03	36	248.55	306.71
LUAD	0.097	1.80e-01	4.10e-01	7248	320.93	397.7
LUSC	− 0.088	1.90e-01	7.01e-01	4467	629.89	713.28
OV	− 0.003	9.70e-01	9.93e-01	16,448	503.56	601.14
PAAD	0.228	4.10e-02	1.63e-01	4299	207.07	238.52
READ	− 0.188	3.80e-01	9.57e-01	6463	643.34	675.6
SARC	0.133	2.00e-01	4.83e-01	6586	440.14	578.62
SKCM	0.052	4.40e-01	6.36e-01	11,030	447.42	528.58
STAD	− 0.169	5.30e-02	3.49e-01	2548	483.32	521.53
UCEC	0.121	3.00e-01	9.88e-01	4955	460.41	528.01

Significantly different results are displayed in this table (P < 0.05)